Carrageenan Gum and Adherent Invasive Escherichia coli in a Piglet Model of Inflammatory Bowel Disease: Impact on Intestinal Mucosa-associated Microbiota by Peris M. Munyaka et al.
ORIGINAL RESEARCH
published: 05 April 2016
doi: 10.3389/fmicb.2016.00462
Frontiers in Microbiology | www.frontiersin.org 1 April 2016 | Volume 7 | Article 462
Edited by:
Janice Lorraine Strap,
University of Ontario Institute of
Technology, Canada
Reviewed by:
François Thomas,
Centre National de la Recherche
Scientifique, France
Jan S. Suchodolski,
GI Lab, Texas A&M University, USA
Benoit Chassaing,
Georgia State University, USA
*Correspondence:
Ehsan Khafipour
ehsan.Khafipour@umanitoba.ca;
Jean-Eric Ghia
jean-Eric.Ghia@umanitoba.ca
Specialty section:
This article was submitted to
Systems Microbiology,
a section of the journal
Frontiers in Microbiology
Received: 25 November 2015
Accepted: 21 March 2016
Published: 05 April 2016
Citation:
Munyaka PM, Sepehri S, Ghia J-E and
Khafipour E (2016) Carrageenan Gum
and Adherent Invasive Escherichia coli
in a Piglet Model of Inflammatory
Bowel Disease: Impact on Intestinal
Mucosa-associated Microbiota.
Front. Microbiol. 7:462.
doi: 10.3389/fmicb.2016.00462
Carrageenan Gum and Adherent
Invasive Escherichia coli in a Piglet
Model of Inflammatory Bowel
Disease: Impact on Intestinal
Mucosa-associated Microbiota
Peris M. Munyaka 1, 2, Shadi Sepehri 3, Jean-Eric Ghia 1, 3, 4, 5* and Ehsan Khafipour 2, 3, 6*
1Department of Immunology, University of Manitoba, Winnipeg, MB, Canada, 2Department of Animal Science, University of
Manitoba, Winnipeg, MB, Canada, 3Children Hospital Research Institute of Manitoba, Winnipeg, MB, Canada, 4 Section of
Gastroenterology, Department of Internal Medicine, Winnipeg, MB, Canada, 5 Inflammatory Bowel Disease Clinical &
Research Centre, University of Manitoba, Winnipeg, MB, Canada, 6Department of Medical Microbiology, University of
Manitoba, Winnipeg, MB, Canada
Inflammatory bowel diseases (IBD) including Crohn’s disease (CD), and ulcerative colitis
(UC), are chronic conditions characterized by chronic intestinal inflammation. Adherent
invasive Escherichia coli (AIEC) pathotype has been increasingly implicated in the
etiopathogenesis of IBD. In a 21-day study, we investigated the effects of AIEC strain
UM146 inoculation on microbiota profile of the ileal, cecal, ascending and descending
colon in a pig model of experimental colitis. Carrageenan gum (CG) was used to induce
colitis in weaner piglets whereas AIEC strain UM146 previously isolated from a CD
patient was included to investigate a cause or consequence effect in IBD. Treatments
were: (1) control; (2) CG; (3) AIEC strain UM146; and (4) CG+UM146. Pigs in groups 2
and 4 received 1% CG in drinking water from day 1 of the study while pigs in groups
3 and 4 were inoculated with UM146 on day 8. Following euthanization on day 21,
tissue mucosal scrapings were collected and used for DNA extraction. The V4 region of
bacterial 16S rRNA gene was then subjected to Illumina sequencing. Microbial diversity,
composition, and the predicted functional metagenome were determined in addition to
short chain fatty acids profiles in the digesta and inflammatory cytokines in the intestinal
tissue. CG-induced colitis decreased bacterial species richness and shifted community
composition. At the phylum level, an increase in Proteobacteria and Deferribacteres and
a decrease in Firmicutes, Actinobacteria, and Bacteroidetes were observed in CG and
CGUM146 compared to control and UM146. The metabolic capacity of the microbiome
was also altered in CG and CGUM146 compared to UM146 and control in the colon. We
demonstrated that CG resulted in bacterial dysbiosis and shifted community composition
similar to what has been previously observed in IBD patients. However, AIEC strain
UM146 alone did not cause any clear changes compared to CG or control in our
experimental IBD pig model.
Keywords: pigs, carrageenan gum, adherent invasive Escherichia coli, ulcerative colitis, Crohn’s disease, 16S
rRNA gene sequencing, microbiome
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INTRODUCTION
Inflammatory bowel diseases (IBD), including Crohn’s disease
(CD), and ulcerative colitis (UC), are a group of inflammatory
conditions related to the colon and small intestines and
characterized by chronic inflammation. The etiopathology
includes genetic susceptibility, environmental factors,
deregulation of the immune system, and host relationship
with commensal microbiota, as well as abnormal interactions
between the intestinal microbiota and immune system (Abraham
and Medzhitov, 2011; Khor et al., 2011; Maloy and Powrie,
2011; Manichanh et al., 2012). The intestinal microbiota plays a
major role in gut development and in host homeostasis through
development of immune regulation via inhibition of responses
to inappropriate targets, such as gut contents and allergens, and
by turning off inappropriate background inflammation (Hooper
et al., 2002; Guarner, 2005). Therefore, abnormal shifts in the
intestinal microbiota, termed dysbiosis, may lead to adverse
health effects in the host, and could be critical in the pathogenesis
and severity of IBD (Manichanh et al., 2006; Frank et al., 2007;
Honda and Littman, 2012; Morgan et al., 2012; Fite et al., 2013).
In this context, mice genetically modified for IBD do not develop
colitis under germ-free conditions (Horwitz, 2007; Vijay-Kumar
et al., 2007, 2010), and the therapeutic effect of antibiotics further
supports bacterial contribution in the pathogenesis of IBD
(Chapman et al., 1986; van Kruiningen, 1995; Vijay-Kumar et al.,
2010).
A significant reduction in gut microbial diversity, which is
characterized by a marked increase in the phylum Proteobacteria
especially within Enterobacteriaceae family, or a decrease in the
phylum Firmicutes (e.g., Faecalibacterium prausnitzii) has been
observed in patients with IBD (Ott et al., 2004; Lupp et al., 2007;
Sepehri et al., 2007; Sokol et al., 2008, 2009; Friswell et al., 2010;
Qiu et al., 2013; Cao et al., 2014; Walters et al., 2014; Wright
et al., 2015). Generally, the breakdown in the balance between
“mutualistic and commensal” vs. “opportunistic and pathogenic”
intestinal bacteria, largely characterized by reduced abundance of
members of Firmicutes, Actinobacteria, and Bacteroidetes, and
an increase in Proteobacteria and in some cases Bacteroidetes,
is suggested to promote chronic intestinal inflammation (Sokol
et al., 2008; Man et al., 2011; Walters et al., 2014; Wright et al.,
2015).
Increased abundance of members of the Enterobacteriaceae
family, especially Escherichia coli, have been observed in humans
and dogs with IBD and also in experimental animal models
of IBD (Sellon et al., 1998; Darfeuille-Michaud et al., 2004;
Schuppler et al., 2004; Mylonaki et al., 2005; Kotlowski et al.,
2007; Lupp et al., 2007; Xenoulis et al., 2008; Sepehri et al., 2009,
2011; Wright et al., 2015). Although, the adherent-invasive E. coli
(AIEC) pathotype has been repeatedly identified in the intestinal
mucosa of patients with CD (Darfeuille-Michaud et al., 1998,
2004; Agus et al., 2014), it is still difficult to pinpoint whether
AIEC triggers intestinal inflammation leading to the disease, or
if they colonize the gut mucosa as a consequence of pre-existing
inflammation (Martin et al., 2004; Agus et al., 2014). Therefore,
a cause and consequence relationship between E. coli strains and
IBD is yet to be determined. To further investigate the role of
AIEC in IBD, several AIEC strains, including LF82 and UM146,
have been isolated from IBD patients and characterized (Miquel
et al., 2010; Krause et al., 2011; Sepehri et al., 2011; Desilets et al.,
2016). Strain UM146 was previously isolated in our lab from a
CD patient and shown to be able to invade and replicate within
macrophages, which is characteristic of an AIEC (Krause et al.,
2011; Sepehri et al., 2011).
In the present study, we used a pig model of carrageenan
gum (CG)-induced colitis to investigate the possible role of
AIEC strain UM146 in IBD. Pigs share a similar gastrointestinal
morphology and physiology with humans (Miller and Ullrey,
1987; Heinritz et al., 2013), which makes them more suitable
model for human studies. CG, a sulfated polysaccharide, has
been used in different animal models (mouse, guinea pig, rat,
rabbit, rhesus monkey) to chemically induce intestinal ulceration
or inflammation (Watt et al., 1979; Tobacman, 2001). The focus
of these studies has been on the dynamic and profile of mucosal
response in relation to CG-induced colitis and its similarity to
that observed in IBD patients. However, there is no detailed and
clear understanding of the structural and functional alterations of
the intestinal microbiota in response to CG-induced colitis.
Here, we used Illumina high-throughput sequencing of the
16SrRNA gene and inferred metagenomics by PICRUSt to
investigate differences in microbial composition and function
in the ileum, cecum, ascending, and descending colon tissue
samples of piglets with CG-induced colitis and inoculated
with AIEC strain UM146. We demonstrated that CG-induced
colitis influenced bacterial diversity and caused community
composition changes at the phylum and lower taxonomical
levels that are comparable to microbial changes observed in IBD
patients. However, these changes were not observed in AIEC
strain UM146 treatment. Similarly, the combination of CG and
UM146 did not significantly influence the extent of the observed
changes during CG-induced colitis.
MATERIALS AND METHODS
Animals and Housing
A total of 24 male piglets [Duroc × (Yorkshire × Landrace)]
weaned at 17 ± 2 d were obtained from Sunnyside Colony
(Newton Siding, Manitoba, Canada). The pigs were housed in
a temperature-controlled room within the T. K. Cheung Center
for Animal Science Research, University of Manitoba (Winnipeg,
MB, Canada). Room temperatures were maintained at 30◦C
during week (wk) 1 and 29◦C during wk 2 and 3, with a 16
h lighting system. All pigs had ad libitum access to water and
a basal diet in mash form formulated to meet or exceed the
National Research Council (NRC, 2012) recommendations for a
7–11 kg pig. The experiment lasted for 21 days and the pigs were
allowed to acclimate for 3 days before the start of experimental
treatments.
Ethical Considerations
The procedures were approved by the Protocol Management
and Review Committee of the University of Manitoba Animal
Care Committee, and the pigs were cared for according to the
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guidelines of the Canadian Council of Animal Care (CCAC,
1993).
Carrageenan Gum
To induce mild ulcers on the intestinal tract of pigs, a 1% CG
solution prepared from carrageenan powder (CarboMer, Inc.,
San Diego, CA, USA), a sulfated polysaccharide that induces
predominantly mucosal and submucosal lesions with histological
similarity to UC (Elson et al., 1995), was administered. The
CG was administered via drinking water using elevated jugs
connected to normal drinking nipples. The 1% concentration was
chosen based on a pilot study conducted prior to this experiment
(data not shown) where 0, 1, 2, and 4% CG concentrations were
tested. Administration of 1% CG in drinking water only induced
a mild injury in the pigs’ gastrointestinal (GI) tract with varying
degree of mucosa and sub mucosal edema, but without any
granulomatous inflammation which is similar to what is observed
in UC.
Preparation of Carrageenan Gum
Undegraded CG has molecular weights of Mn 1.5 × 10
6 to
2 × 107 (Tong et al., 1980; Tobacman, 2001) and it is generally
considered safe; however, degradation of CG to low molecular
weights is associated with ulcerations and cancer-promoting
effects (Watt et al., 1979; Tobacman, 2001). The solution used
in this study was prepared by acid hydrolysis according to
the procedure described previously (Watt et al., 1979), and is
expected to yield a degraded carrageenan of average molecular
weight of Mn 2 × 10
4 to 3 × 104 (Weiner, 1991; Marcus et al.,
1992). Briefly, to each gram of the dry powder, one mL of
concentrated HCl was added in a glass beaker and thoroughly
mixed at room temperature (22◦C) with a glass rod for 1 h. After
1 h, distilled water was added while stirring the mixture. The
acidified solution was neutralized with 2 M sodium hydroxide
to pH of 7–8 and the volume was adjusted to give a 1%
concentration.
Preparation of AIEC Strain UM146
Adherent invasive E. coli (AIEC) strain UM146 previously
isolated from a human subject with CD (Sepehri et al., 2011) was
used in this study. The strain was cultured aerobically in LB broth
and incubated at 37◦C overnight to achieve a concentration of
108–1010 CFU/mL, and 100 mL of the overnight culture was used
for dosing as described below.
Induction of Colitis and Inoculation with
AIEC Strain UM146
Pigs were weighed and randomly assigned to four treatment
groups with three pigs per pen and two replicate pens per
treatment. The treatments were as follows: (1) control; (2) pigs
receiving 1%CG in drinking water; (3) pigs inoculated with AIEC
strainUM146; and (4) as in 2 and 3; CGUM146. From day 1 of the
study, pigs that were assigned to receive carrageenan gum were
given a 1% CG solution in overhead plastic jugs connected to
normal drinking water nipples. Administration of CG was done
on a daily basis until end of the study (21 d). The CG solution
level was monitored and jugs were refilled with freshly prepared
CG every morning (at 9:30 am) and in the evening (at 4:30 pm),
if needed. On day 8 of the study, pigs that were assigned to be
inoculated with UM146 were given an overnight culture of the
AIEC strain UM146 (Table 1). In this case, for each pig, 100 mL
of the overnight culture wasmixed with small amount of feed and
the animals were allowed to consume the freshly mixed feed first.
Fecal Score
Severity of diarrhea was characterized in a treatment-blinded
manner by two trained individuals using a fecal consistency
scoring system, as described previously (Marquardt et al., 1999).
The scoring system was as follows: 0, normal; 1, soft feces; 2, mild
diarrhea; and 3, severe diarrhea. Scoring was done at 48 h, 96 h, 7
d, and 14 d after inoculation with AIEC strain UM146.
Tissue and Digesta Sampling
On days 21 and 22 of the study, all pigs were sedated by
intramuscular injection of Ketamine:Xylazine (20:2 mg/kg BW)
and euthanized by an intracardiac injection of 110 mg/kg
BW sodium pentobarbital (Bimeda-MTC Animal Health Inc.,
Cambridge, ON, Canada). The abdominal cavity was opened
from sternum to pubis to expose the gastrointestinal tract without
damaging the wall of the digestive tract. The small intestine
was stripped free of its mesentery and ileal, cecal, and colon
digesta samples were obtained, divided into two sub-samples
and transferred to sterile sample bags. One sub-sample of the
digesta was used for determination of pH, whereas the second
sub-sample was kept on ice and later transferred to −20◦C for
later analysis of volatile fatty acids (VFA). Tissue samples (two
5 cm long segments) were collected from the ileum, cecum,
ascending and descending colon, flushed with sterile saline to
remove excess lumen contents, immediately frozen in liquid
nitrogen and transferred to−80◦C until used for DNA extraction
and further molecular/microbial analyses.
Analysis of pH, Ammonia N, and Volatile
Fatty Acids
pH was measured immediately after digesta collection using
an Accumet Basic 15 pH meter (Fisher Scientific, Fairlawn,
NJ) equipped with a Sensorex 450C Flat Surface Combination
pH/Reference Electrode (Sensorex, Stanton, CA), which was
standardized with certified pH 4 and 7 buffer solutions.
Ammonia nitrogen concentration was measured using a
calorimetric technique as described previously (Novozamsky
et al., 1974), while volatile fatty acids (VFA) were determined
using gas chromatography (Bhandari et al., 2007).
Characterization of Inflammatory
Responses
Tissue samples were homogenized (50 mg/mL) in Tris lysis
buffer (Meso scale discovery diagnostics, Rockvile, MD, USA)
containing protease inhibitors (Roche, Mississauga, ON,
Canada). Samples were centrifuged at 3000 × g for 10 min
and the supernatant was recovered and stored at −80◦C until
analyzed. Cytokine levels [interleukin (IL)-1β, IL-6, IL-8,
IL-10, and tumor necrotic factor (TNF)-α] were determined
using a custom meso scale porcine kit (Meso scale discovery
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TABLE 1 | Schedule of CG and adherent invasive Escherichia coli (AIEC) strain UM146 administrationa.
Treatment
administration
Study day
Adaptation
period (3 days)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
CG (1% in drinking
water; ad libitum)
+ + + + + + + + + + + + + + + + + + + + +
AIEC strain UM146 +
aThe first 3 days served as adaptation period. CG was administered from day 1 of the study until the end of the study, while administration of UM146 was done on day 8 only.
diagnostics, Rockville, MD, USA), according to the manufacturer
instructions.
Correlation Coefficients
Associations between bacterial taxa with an abundance ≥0.5%
of community in the ileum, cecum, and ascending colon
and short chain fatty acids (acetate, propionate, butyrate), or
inflammatory markers (IL-1β, IL-6, IL-8, IL-10, TNF-α) were
explored using non-parametric Spearman’s rank correlation
implemented in PAST software (Hammer et al., 2001). For
each correlation, correlation coefficient (Spearman’s Rho) and
P-value were obtained and the resulting correlation matrix
was visualized in a heatmap format generated by the corrplot
package of R (Corrplot: visualization of a correlation matrix. R
package ver. 02-0.2010; http://CRAN). The correlation coefficient
values ranged from −1 to +1 with larger absolute values
indicating stronger relationship while positive and negative
values indicating the direction of association. Alpha value for the
correlation confidence intervals was set up as 0.05.
DNA Extraction
Tissue samples were thawed at room temperature. The inner
wall was then gently scrapped with a blunt blade to obtain
200–300 mg of mucosa, of which, ∼50 mg was used for DNA
extraction. DNA was extracted using a ZR Tissue and Insect
DNA kit (Zymo Research Corp., Orange, CA), which included
a bead-beating step for the mechanical lysis of the microbial cells.
DNA concentration was determined using a NanoDrop 2000
spectrophotometer (ThermoFisher Scientific, Wilmington, DE,
USA), and the DNA quality was evaluated by PCR amplification
of the 16S rRNA gene using universal primers 27F (5′-GAA
GAGTTTGATCATGGCTCAG-3′) and 342R (5′-CTGCTGCCT
CCCGTAG-3′), as previously described (Khafipour et al., 2009).
Amplicons were verified using agarose gel electrophoresis.
Library Construction and Illumina
Sequencing
The V4 region of 16S rRNA gene was targeted for PCR
amplification using modified F515/R806 primers (Caporaso
et al., 2012), as previously described (Derakhshani et al., 2016).
Briefly, the reverse PCR primer was indexed with 12-base
Golay barcodes allowing for multiplexing of samples. The PCR
reaction for each sample was performed in duplicate and
contained 1.0 µL of pre-normalized DNA (20ng/µL), 1.0 µL
of each forward and reverse primers (10 µM), 12 µL HPLC
grade water (Fisher Scientific, Ottawa, ON, Canada), and 10
µL 5 Prime Hot MasterMix (5 Prime, Inc., Gaithersburg,
MD, USA). Reactions consisted of an initial denaturing step
at 94◦C for 3 min followed by 35 amplification cycles at
94◦C for 45 s, 50◦C for 60 s, and 72◦C for 90 s, and an
extension step at 72◦C for 10 min in an Eppendorf Mastercycler
pro (Eppendorf, Hamburg, Germany). PCR products were
then purified using ZR-96 DNA Clean-up KitTM (ZYMO
Research, Irvine, CA, USA) to remove primers, dNTPs, and
reaction components. The V4 library was then generated by
pooling 200 ng of each sample and quantified using Picogreen
(Invitrogen, Burlington, NY, USA). This was followed by
multiple dilution steps using pre-chilled hybridization buffer
(HT1; Illumina, San Diego, CA, USA) to bring the pooled
amplicons to a final concentration of 5 pM, measured by Qubit
2.0 Fluorometer (Life technologies, Burlington, ON, Canada).
Finally, 15% of PhiX control library was spiked into the
amplicon pool to improve the unbalanced and biased base
composition, a known characteristic of low diversity 16S rRNA
libraries. Customized sequencing primers for read1 (5′-TATGGT
AATTGTGTGCCAGCMGCCGCGGTAA-3′), read2 (5′-AGT
CAGTCAGCCGGACTACHVGGGTWTCTAAT-3′), and index
read (5′-ATTAGAWACCCBDGTAGTCCGGCTGACTGACT-
3′; Integrated DNA Technologies, Coralville, IA, USA) were
added to the MiSeq Reagent V2 Kit (300-cycle; Illumina, San
Diego, CA, USA). The 150 paired-end sequencing reaction was
performed on a MiSeq platform (Illumina, San Diego, CA,
USA) at the Gut Microbiome and Large Animal Biosecurity
Laboratories (Department of Animal Science, University of
Manitoba, Winnipeg, MB, Canada). The sequencing data were
uploaded into the Sequence Read Archive (SRA) of NCBI
(http://www.ncbi.nlm.nih.gov/sra) and can be accessed through
accession number SRR2601043.
Bioinformatic Analyses
The PANDAseq assembler (Masella et al., 2012) was used
to merge overlapping paired-end Illumina fastq files. All the
sequences with low quality base calling scores as well as
those containing uncalled bases in the overlapping region
were discarded. The output fastq file was then analyzed by
downstream computational pipeline of the open source software
package QIIME (Caporaso et al., 2010b). Assembled reads were
demultiplexed according to the barcode sequences and chimeric
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reads were filtered using UCHIME (Edgar et al., 2011) and
sequences were assigned to Operational Taxonomic Units (OTU)
using the QIIME implementation of UCLUST (Edgar, 2010)
at 97% pairwise identity threshold using an open-reference
OTU picking process (Rideout et al., 2014). Taxonomies were
assigned to the representative sequence of each OTU using RDP
classifier (Wang et al., 2007) and aligned with the Greengenes (v.
13.5) reference database (DeSantis et al., 2006) using PyNAST
algorithms (Caporaso et al., 2010a). Phylogenetic tree was built
with FastTree 2.1.3. (Price et al., 2010).
Alpha- and Beta-Diversities
Within-community diversity (α-diversity) was calculated by
different indices of species richness and evenness including
observed number of species, Chao1, abundance-based
coverage estimator (ACE), Shannon, Simpson, Inverse
Simpson (InvSimpson), and Fisher using the open source
R software (3.1.0). The P-values were calculated using the
SAS MIXED procedure (SAS 9.3). An even depth of 5000,
4000, 12,000, and 10,000 sequences per sample was used to
calculate the richness and diversity indices for the ileum,
cecum, ascending, and descending colon, respectively. To
assess the beta-diversity (β-diversity) differences among
bacterial communities from different treatments within
each compartment, non-metric multidimensional scaling
(nMDS) ordination plots were generated using R software
(3.1.0) by employing Bray-Curtis similarity matrices with
a conventional cut-off of <0.2 for the stress value. The
resulting minimum stress solution was used to produce
the nMDS plots, in which each data point represents one
sample. The spatial distance between points in the plot was
interpreted as the relative difference in the bacterial community
composition; thus, points that were closer were more similar
than points that were more distant. To assess the statistical
differences in β-diversity of bacterial communities among
treatment groups, permutation multivariate analysis of variance
(PERMANOVA; Anderson, 2005) was performed and P-values
were calculated.
Partial Least Square Discriminant Analysis
Partial least square discriminant analysis (PLS-DA; SIMCA P+
13.02, Umetrics, Umea, Sweden) was performed on the lower
taxonomic data to identify the effects of CG and UM146 (Li
et al., 2012). The PLS-DA is a particular case of partial least
square regression analysis in which Y is a set of variables
describing the categories of a categorical variable on X. In this
case, X variables were bacterial genera and Y was observations
of different treatments compared together. To avoid over-
parameterization of the model, variable influence on projection
value (VIP) was estimated for each taxa, and taxa with VIP <
0.5 were removed from the final model. R2 estimates were used
to evaluate the goodness of fit and Q2 estimate was used to
evaluate the predictive value of the model. Data are presented
in loading scatter plots. The PLS-DA regression coefficients
were used to identify taxa that were positively or negatively
correlated with each treatment group. The significant shifts of
taxa were determined when the error bars of each component
was above or below x axis of coefficient plot (Wang et al.,
2016).
Prediction of Functional Metagenomics
The open source software PICRUSt (Phylogenetic Investigation
of Communities by Reconstruction of Unobserved States;
v. 1.0.0-dev) was used to predict the functional capacity
of microbiome using 16S rRNA gene sequencing data and
Greengenes (v. 13.5) reference database (DeSantis et al., 2006).
To make our open-reference picked OTUs compatible with
PICRUSt, all de-novo OTUs were removed and only those that
had matching Greengenes identifications were retained. The new
OTU table was then used to generate metagenomic data after
normalizing the data by copy numbers, and to derive relative
Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway
abundance (Langille et al., 2013). The KEGG data was analyzed
using STAMP (STatistical Analysis of Metagenomic Profiles
(Parks and Beiko, 2010). To determine the functional KEGG
pathways that could be associated with the microbial changes
observed, we compared the functional pathways for the mucosal
microbiota of samples from CG and CGUM146 to control or
UM146 at all the intestinal sites (ileum, cecum, ascending and
descending colon).
Other Statistical Analysis
For the fecal score, cytokines, VFAs, pH, ammonia, and
the phylum data, the treatment effect was evaluated using
a completely randomized design and the data was subjected
to ANOVA using the MIXED procedure of SAS (v. 9.3).
Differences between means were determined using Tukey’s
test. SAS UNIVARIATE procedure was used to test the
normality of residuals. For non-normally distributed data,
Poisson and negative binomial distributions were fitted in
GLIMMIX procedure of SAS and the goodness of fit for different
distributions was determined using Pearson chi-square /DF ratio
(closer to 1 is better). In both MIXED and GLIMMIX models,
the effect of treatment was considered fixed and pig were treated
as random factor. The differences between treatments were
considered significant at P < 0.05.
RESULTS
Diarrhea Post-Inoculation with AIEC Strain
UM146
At 48 h post-inoculation, diarrhea was observed in colitic pigs
that were also inoculated with E. coli (CGUM146 treatment) but
not in the other treatment groups (Figure 1A). At 96 h post-
inoculation, pigs in UM146 treatment had soft feces (an average
fecal score of 1.5) compared to pigs in other treatments that
experienced mild diarrhea (an average fecal score of 2.5).
Volatile Fatty Acids, Ammonium N, and pH
in the Ileum, Cecum and Colon
As shown in Table 2, ammonium N and pH were similar
among treatments in the ileum, cecum and colon except
for a lower ammonium N in the cecum that was observed
in the UM146 treatment compared to the control. VFA
concentrations were not different among treatment groups in
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FIGURE 1 | (A–F) The effect of carrageenan gum (CG) and adherent invasive Escherichia coli (AIEC) strain UM146 inoculation on fecal score, as determined by stool
consistency, and on inflammatory markers (IL-1β, IL-6, IL-8, IL-10, and TNF-α) in weaned pigs. CG was administered to the designated groups from day 1 of the
experiment. CG: pigs received 1% carrageenan gum only in drinking water daily; UM146: pigs were inoculated with AIEC UM146 on day 8; CGUM146: pigs received
CG from day 1 and were inoculated with AIEC UM146 on day 8. Pigs in designated groups received 100 mL of AIEC UM146 culture (108 CFU/mL) in feed. Severity of
diarrhea was characterized using an established fecal consistency (FC) score system in pigs (0, normal; 1, soft feces; 2, mild diarrhea; 3, severe diarrhea). *Designates
a significant difference compared to other groups; P < 0.05.
the ileum. In both cecum and colon, butyrate was significantly
lower in the CG treatment compared to UM146, but the
difference wasn’t significant compared to other treatments.
In addition, colonic acetate was significantly lower in both
CG and CGUM146 treatments compared to the control, but
there was no significant difference compared to the UM146
treatment.
Inflammatory Cytokines in the Ileum,
Cecum, Ascending, and Descending Colon
Among the cytokines analyzed in the four intestinal segments
on day 21, CGUM146 treatment up-regulated IL-8 and IL-6 in
the descending colon and ileum, respectively, whereas UM146
up-regulated IL-10 in the descending colon. IL-1β and TNF-α
did not differ among treatment groups in all intestinal segments
examined (Figures 1B–F).
Correlation Coefficient
As shown in Table 3 and Supplementary Figures 1–3, several
taxa were positively or negatively correlated with various short
chain fatty acids and/or inflammatory markers in the ileum,
cecum and ascending colon.
Alpha-Diversity in Different Intestinal
Segments
As shown in Table 3, no significant difference was observed
among treatment groups in the ileum. Also, according to most
of the diversity indices calculated, lower bacterial diversity was
observed in both CG and CGUM146 treatments compared to
control and UM146 in the cecum, ascending and descending
colon.
Beta-Diversity Differences among
Treatment Groups in the Ileum, Cecum,
Ascending, and Descending Colon
As shown in Figures 2A–D, PERMANOVA analysis of beta-
diversity data showed significant difference between treatment
groups in the cecum (P = 0.013) and descending colon (P =
0.0014). In this context, cecal, and descending colon samples
clustered separately according to treatment status of the pig,
suggesting that the samples are composed of distinct bacterial
communities.
In the ileum and ascending colon although overall P-values
were not significant (ileum, P = 0.0612; ascending colon, P =
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TABLE 2 | Effect of carrageenan gum (CG)1 and adherent invasive Escherichia coli (AIEC) strain UM1462 inoculation on microbial activities in the ileum,
cecum and colon digesta of weaned pigs, as determined by changes in the level of pH, ammonium nitrogen (N), and volatile fatty acids (VFA).
Item Treatment3 SED4 P-value5
Control CG UM146 CGUM146
pH
Ileum 6.00 6.06 5.62 6.20 0.37 0.4667
Cecum 5.63 5.59 5.55 5.68 0.17 0.9044
Colon 5.84 6.01 5.82 5.84 0.15 0.6118
AMMONIUM N, mg/dL
Ileum 23.86 23.62 19.13 19.97 3.4 0.4165
Cecum 17.01a 14.43ab 10.51b 14.61ab 2.3 0.0729
Colon 35.95 30.83 30.75 27.83 4.7 0.4113
ILEUM VFA, mmol/mL
Acetate 8.17 6.47 4.33 6.57 1.48 0.1590
Propionate 0.25 0.23 0.11 0.30 0.11 0.4697
Butyrate 0.39 0.04 0.69 0.37 0.35 0.3823
Valerate 0.29 0.21 0.22 0.27 0.09 0.7313
Iso-butyrate 0.49 0.37 0.28 0.28 0.4 0.9473
Iso-valerate 0.48 0.33 0.42 0.38 0.16 0.8369
CECAL VFA, mmol/mL
Acetate 48.6 38 56 45.54 6.8 0.1017
Propionate 24.86 28 32.37 26.12 4.4 0.3785
Butyrate 13.94ab 8.9b 21.42a 18.58ab 4.1 0.0352
Valerate 3.52 2.39 6.09 6.55 1.7 0.0695
Iso-butyrate 0.12 0.20 0.32 0.23 0.09 0.2715
Iso-valerate 0.31 0.35 0.55 0.51 0.15 0.3391
COLON VFA, mmol/mL
Acetate 54.88a 42.12b 50.34ab 42.35b 4.3 0.0185
Propionate 24.39 24.69 27.04 20 3.3 0.2390
Butyrate 14.91ab 9.75b 17.06a 13.79ab 1.9 0.0114
Valerate 4.37 3.36 5.17 4.86 1.02 0.3377
Iso-butyrate 0.3 0.14 0.34 0.21 0.08 0.1023
Iso-valerate 0.81 0.67 0.80 0.64 0.18 0.7186
a,bMeans with different superscripts within the same row differs significantly; P < 0.05.
1Carrageenan gum (CG) was administered in the designated groups from day 1 of the experiment. Pigs received 1% CG in drinking water on daily basis.
2AIEC UM146 inoculation was administered on day 8. Pigs in designated groups received 100 mL of an overnight AIEC UM146 culture (108 CFU/mL) in feed.
3CG: pigs received 1% CG only in drinking water daily; UM146: pigs were inoculated with AIEC UM146 on day 8; CGUM146: pigs received CG from day 1 and were inoculated with
AIEC UM146 on day 8.
4SED: standard error of difference between treatment means.
5Significant P-values are highlighted with bold font.
0.0545) pair-wise comparisons between control vs. CGUM146
(P = 0.0327) and UM146 vs. CG (P = 0.0287) in the ileum, and
UM146 vs. CGUM146 (P = 0.0145) in the ascending colon were
significant.
Microbiota Composition at the Phylum and
Lower Taxonomic Levels in Different
Intestinal Segments
Ileum
A total of 266,412 quality-filtered sequences were obtained from
the samples with an average of 11,583 sequences per sample.
Fourteen phyla were identified in all the samples. Among the
most abundant phyla, Firmicutes was themost dominant phylum
but the phyla did not differ significantly between treatment
groups (Figure 3A, Supplementary Table 1.) Classification of
OTUs at lower taxonomical levels resulted in the identification
of 191 taxa of which 95 were ≥0.01% of the community, while
96 taxa were <0.01% of the community. Bacterial taxa with
relative abundance of >0.01% of community were analyzed
using PLS-DA to identify taxa that were most characteristic
of different treatment groups and the results are shown in
Figures 4A,B. Supplementary Table 2 shows a summary of the
mean abundance of all the taxa.
Cecum
A total of 571,706 quality-filtered sequences were obtained
from the samples with a mean of 19,056 sequences per
sample. Sixteen phyla were identified in all the samples.
Among the most abundant phyla, Bacteroidetes proportion was
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TABLE 3 | Alpha-diversity indices of the ileal, cecal, ascending, and descending colon mucosa-associated microbiota of pigs treated with carrageenan
gum (CG)1 and inoculated with adherent invasive Escherichia coli (AIEC) strain UM1462.
Items Treatment3 SED4 P-value5
Control UM146 CG CGUM146
ILEUM
Observed species 95.16 100.25 105.70 147.17 36.20 0.43
Chao1 176.75 163.61 179.67 245.36 57.40 0.54
ACE 191.20 170.51 202.32 263.20 68.30 0.56
Shannon 1.71 1.76 1.98 2.64 0.60 0.45
Simpson 0.58 0.48 0.60 0.76 0.15 0.40
InvSimpson 2.93 2.63 2.59 5.35 1.10 0.06
Fisher 22.14 25.93 24.13 37.80 10.20 0.47
CECUM
Observed species 442.29a 422.33a 255.71b 337.50ab 68.50 0.05
Chao1 765.11a 736.57a 439.83b 623.27ab 124.00 0.07
ACE 845.64a 790.69a 482.55b 576.43ab 115.00 0.01
Shannon 3.50 3.47 2.42 2.91 0.47 0.11
Simpson 0.90a 0.92a 0.70b 0.80ab 0.07 0.02
InvSimpson 13.18a 13.54a 4.00b 5.40b 3.40 0.01
Fisher 120.14a 122.11a 58.25b 84.91ab 20.80 0.02
ASCENDING COLON
Observed species 912.43a 807.33ab 574.00b 537.22b 126.00 0.01
Chao1 1597.16a 1329.93a 985.36ab 783.04b 268.00 0.02
ACE 1737.07a 1425.97ab 1049.47ab 826.98b 296.00 0.02
Shannon 4.25a 4.20ab 3.12b 3.59ab 0.04 0.05
Simpson 0.93a 0.925a 0.77b 0.88ab 0.06 0.04
InvSimpson 21.45a 18.210a 5.15b 10.14ab 4.70 <0.01
Fisher 242.25a 201.67ab 137.39b 121.39b 27.80 0.02
DESCENDING COLON
Observed species 1012.29a 989.67a 652.14b 680.29b 143.00 0.02
Chao1 1800.90 1726.70 1195.66 1180.20 332.00 0.13
ACE 1942.05 1928.19 1280.03 1331.88 360.00 0.14
Shannon 0.97a 0.95a 0.86b 0.90ab 0.03 <0.01
Simpson 289.74 280.52 165.38 176.30 47.90 0.02
InvSimpson 40.75a 28.54ab 13.39b 12.61b 6.00 <0.01
Fisher 289.74a 280.52ab 165.38b 176.30ab 47.80 0.02
a,bMeans with different superscripts within the same row differs significantly; P < 0.05.
1Carrageenan gum was administered to the designated groups from d 1 of the experiment. Pigs received 1 % of CG in drinking water on daily basis.
2AIEC UM146 inoculation was administered on d 8 of the experiment. Pigs in designated groups received 100 mL of an overnight AIEC UM146 culture (108 CFU/mL) in feed.
3CG = pigs received 1% carrageenan gum only in drinking water on daily basis, UM146 = pigs were inoculated with AIEC UM146 on d 8 of the study, CGUM146 = pigs received CG
from d 1 of the study and were inoculated with AIEC UM146 on d 8 of the study.
4SED: standard error of difference between treatment means.
5Significant P-values are highlighted with bold font.
lower (P = 0.002) in the CG compared to the control and
UM146 treatments, but it was not different from CGUM146
(Figure 3B, Supplementary Table 1). Classification of OTUs at
lower taxonomical levels resulted in identification of 177 taxa, of
which 76 were ≥ 0.01% of the community, and the rest were <
0.01% of the community. Bacterial taxa with a relative abundance
of ≥0.01% of the community were analyzed using PLS-DA
to identify bacteria that were most characteristic of different
treatment groups and the results are shown in Figures 5A,B.
Supplementary Table 3 shows a summary of mean abundances
of all the taxa.
Ascending Colon
A total of 1,293,477 quality-filtered sequences were obtained
from the samples with an average of 41,725 sequences per sample.
Twenty phyla were identified in all the samples. Among the
most abundant phyla, the proportion of Firmicutes was lower
(P = 0.007) in CG and CGUM146 groups, while Proteobacteria
(P = 0.001) and Deferribacteres (P = 0.039) were higher in
these groups compared to control and UM146 treatments. In
addition, Bacteroidetes abundance was lower (P < 0.0001)
in the CG group but not different from UM146 compared
to the other treatments (Figure 3C, Supplementary Table 1).
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FIGURE 2 | Non-metric multidimensional scaling (nMDS) ordination plot, a measure of relative difference in the bacterial community composition in
the: (A) ileum; (B) cecum; (C) ascending colon; and (D) descending colon of pigs treated with carrageenan gum (CG) and inoculated with adherent
invasive Escherichia coli (AIEC) strain UM146. The colored points are shaded according to different treatment groups. CG: pigs received 1% carrageenan gum
only in drinking water daily; UM146: pigs were inoculated with AIEC UM146 on day 8 of the study; CGUM146: pigs received CG from day 1 of the study and were
inoculated with AIEC UM146 on day 8 of the study. Pigs in designated groups received 100 mL of AIEC UM146 culture (108 CFU/mL) in feed. The P-values were
calculated using PERMANOVA. For the pair-wise tests, only the significant P-values are included.
Classification of OTUs at lower taxonomical levels resulted in
the identification of 232 taxa of which 81 were ≥0.01% of the
community, while 151 were <0.01% of the community. Bacterial
taxa with a relative abundance of ≥0.01% of the community
were analyzed using PLS-DA to identify bacteria that were
most characteristic of different treatment groups. The results
are shown in Figures 6A,B. Supplementary Table 4 shows a
summary of mean abundances of all the taxa.
Descending Colon
A total of 1,148,413 quality-filtered sequences were obtained
from the samples with a mean of 39,600 sequences per sample.
Seventeen phyla were identified in all the samples. Among
the most abundant phyla, the proportion of Firmicutes and
Tenericutes were lower (P = 0.0055 and 0.0047, respectively) in
the CG and CGUM146 treatments compared to the control, but
wasn’t different compared to UM146. Proteobacteria abundance
was higher (P < 0.0001) in CG treatment compared to other
treatments. Conversely, the proportion of Bacteroidetes was
lower (P< 0.0001) in CG treatment compared to other treatment
groups (Figure 3D, Supplementary Table 1).
Classification of OTUs at lower taxonomical levels resulted in
the identification of 181 taxa, of which 84 were ≥0.01% of the
community, while 97 were <0.01% of the community. Bacterial
taxa with a relative abundance of ≥0.01% of the community
were analyzed using PLS-DA to identify bacteria that were
most characteristic of different treatment groups. The results
are shown in Figures 7A,B. Supplementary Table 5 shows a
summary of mean abundance of all the taxa.
Functional Metagenome of Microbiomes
A closed-reference based OUT picking step was employed for the
PICRUST (v. 1.0.0-dev) analysis using the Greengenes (v.13.5)
database. The proportion of reads that mapped to reference
during OTU picking was 96.7% for the ileum, 91.4% for the
cecum, 88.1% for the ascending colon, and 85.7% for the
descending colon (an average of 90.5% for all the tissues). The
data was normalized by copy numbers before metagenomes
prediction, and the Nearest Sequenced Taxon Index (NSTI) for
each sample which reflects the availability of reference genomes
that are closely related to the abundant microorganisms in the
samples were determined during metagenome prediction. On
average, the NSTIs were: 0.06 for the ileum, 0.06 for the cecum,
0.10 for ascending colon, and 0.10 for descending colon. High
NSTI scores (>0.15) are indicative that fewer related references
are available and predictions were of low quality whereas low
scores (<0.06) are reflective of availability of closely related
reference genomes.
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FIGURE 3 | Percentage of relative abundance of bacterial phyla in the: (A) ileum; (B) cecum; (C) ascending colon; and (D) descending colon of pigs
treated with carrageenan gum (CG) and inoculated with adherent invasive Escherichia coli (AIEC) strain UM146. (A) Ileum: A total of 14 phyla were
identified in all the samples, of which four were considered to be abundant within the community (≥1%), including Firmicutes, Bacteroidetes, Proteobacteria, and
Tenericutes. Among the abundant phyla, Firmicutes was the most dominant phylum but its proportion did not differ among treatment groups. (B) Cecum: A total of
16 phyla were identified in all the samples, of which four were considered to be abundant within the community (≥1%), including Firmicutes, Bacteroidetes,
Proteobacteria, and Deferribacteres. Among these abundant phyla, the proportion of Proteobacteria was slightly higher (P < 0.05) in the CG and CGUM146 groups
compared to the control and UM146 treatments, whereas Bacteroidetes was lower (P < 0.05) in the CG and CGUM146 groups compared to the control and UM146
treatments. (C) Ascending colon: A total of 20 phyla were identified in all the samples, of which five were considered to be abundant within the community (≥1%),
including Firmicutes, Bacteroidetes, Proteobacteria, Deferribacteres, and Spirochaetes. The proportion of Firmicutes was lower in CG and CGUM146 groups (P =
0.007), while Proteobacteria (P = 0.001) and Deferribacteres (P = 0.039) were higher in these groups compared to control and UM146 treatments. Bacteroidetes
abundance was lower (P < 0.0001) in CG treatment compared to other groups whereas Spirochaetes did not differ among groups (P > 0.05). (D) Descending
colon: A total of 17 phyla were identified in all the samples, of which five were considered to be abundant within the community (≥1%), including Firmicutes,
Bacteroidetes, Proteobacteria, Deferribacteres, and Tenericutes. The proportion of Firmicutes was lower (P = 0.0055) in the CG and CGUM146 treatments while
Proteobacteria proportion was higher (P < 0.0001) in these groups compared to the control and UM146 treatments. The Bacteroidetes proportion was lower (P <
0.0001) in CG treatment compared to other treatment groups. CG: pigs received 1% CG only in drinking water daily; UM146: pigs were inoculated with AIEC UM146
on day 8; CGUM146: pigs received CG from day 1 and were inoculated with AIEC UM146 on day 8. Pigs in designated groups received 100 mL of AIEC UM146
culture (108 CFU/mL) in feed.
As shown in Figure 8, different metabolic pathways were
enriched in the mucosal microbiota of the ascending colon
tissue in UM146 including fructose and mannose metabolism,
amino sugar, and nucleotide sugar metabolism, ribosome
biogenesis, DNA replication proteins, and DNA repair and
recombination proteins, among others. Functional pathways
enriched in the ascending colon mucosal microbiota of CG-
or CGUM146-treated pigs include, but are not limited to,
bacterial chemotaxis, flangellar assembly, and lipopolysaccharide
biosynthesis proteins. As shown in Figure 9, different functional
pathways were enriched in the mucosal microbiota of the
descending colon tissue in the control group including,
but not limited to, transporters, transcription factors, DNA
repair, and recombination proteins, and starch and sucrose
metabolism. In addition, several functional pathways were
also enriched in the descending colon mucosal microbiota
of CG- or CGUM146-treated pigs including secretion
system, flagellar assembly, bacterial secretion system, and
lipopolysaccharide biosynthesis proteins. Comparisons with
the control or UM146 in the ascending and descending colon,
respectively, were not significant after correcting the P-values
and therefore, they were not included. Also, no comparisons
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FIGURE 4 | Taxa that were positively or negatively associated with: (A) control or UM146 in the ileum of pigs inoculated with adherent invasive
Escherichia coli (AIEC) strain UM146; (B) CG or CGUM146 in the ileum of pigs treated with CG and inoculated with AIEC UM146. UM146: pigs were
inoculated with AIEC UM146 on day 8; CG: pigs received 1% CG only in drinking water daily; CGUM146: pigs received CG from day 1 and were inoculated with AIEC
UM146 on day 8. Pigs in designated groups received 100 mL of AIEC UM146 culture (108 CFU/mL) in feed.
were included for the ileum and the cecum as there were no
significant differences in pathways after correcting for the
P-values.
DISCUSSION
Changes in microbial composition and its interaction with the
immune system play an important role in the pathogenesis
of IBD (Abraham and Medzhitov, 2011; Khor et al., 2011;
Manichanh et al., 2012; Sartor and Mazmanian, 2012; Hansen,
2015). In this study, we used 16S rRNA gene Illumina sequencing
to investigate differences in the composition and function of
mucosa-associated microbial communities of different GI tract
segments in a piglet model of experimental IBD. In agreement
with previous studies in IBD patients (Sokol et al., 2008; Man
et al., 2011; Walters et al., 2014; Wright et al., 2015), our results
showed that the relative abundance of Proteobacteria was higher
(P = 0.001) in pigs with CG-induced colitis whilst Firmicutes
and Bacteroides were lower (P < 0.001) compared to control in
the large intestine (Figure 3, Supplementary Table 1). Also, pigs
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FIGURE 5 | Taxa that were positively or negatively associated with: (A) CG or CGUM146 in the cecum of pigs treated with CG and inoculated with
adherent invasive Escherichia coli (AIEC) strain UM146; (B) control or UM146 in the cecum of pigs inoculated with AIEC UM146. CG: pigs received 1%
CG only in the drinking water daily; CGUM146: pigs received CG from day 1 and were inoculated with AIEC UM146 on day 8; UM146: pigs were inoculated with AIEC
UM146 on day 8. Pigs in designated groups received 100 mL of AIEC UM146 culture (108 CFU/mL) in feed.
with CG-induced colitis clustered separately from the control
and UM146 in the cecum and descending colon (Figure 2)
indicating a distinct shift in bacterial composition, which is
in line with previous observations in microbiota profiles of
patients with IBD (Ott et al., 2004; Sokol et al., 2008). Metabolic
capacity of the microbiome in the colon of colitic pigs was also
altered (Figures 8, 9) but no significant changes were observed
in UM146 treatment alone compared to the control, and neither
did the combination of CG and UM146 further impact the
extent of observed changes. This indicates that either E. coli
strain UM146 did not successfully colonize the GI tract and
therefore did not have much impact on microbial equilibrium
and inflammation, or that its effects were transient. In addition,
by combining CG-induced colitis and UM146 inoculation, it
was expected that the pigs would experience adverse effects
and manifest more dysbiosis and inflammation compared to
the pigs with colitis alone; however, this was not the case
in our study as the observed changes could only be mainly
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FIGURE 6 | Taxa that were positively or negatively associated with: (A) CG or CGUM146 in the ascending colon of pigs treated with CG and inoculated
with adherent invasive Escherichia coli (AIEC) strain UM146; (B) control or UM146 in the ascending colon of pigs inoculated with AIEC UM146. CG:
pigs received 1% CG only in the drinking water daily; CGUM146: pigs received CG from day 1 and were inoculated with AIEC UM146 on day 8; UM146: pigs were
inoculated with AIEC UM146 on day 8. Pigs in designated groups received 100 mL of AIEC UM146 culture (108 CFU/mL) in feed.
associated with the colitis and not UM146 inoculation. The
lack of clear effects of UM146 could be due to the one time
inoculation that was used in our study and the length of our
study after inoculation. However, AIEC UM146 is well-adapted
to colonize human intestines rather than pigs and, therefore, a
one-time inoculation may not be sufficient for AIEC UM146
to effectively overrun a plethora of indigenous microbes that
colonize pig’s digestive tract. Repeated dosing over a relatively
longer period of time may, therefore, provide a better insight on
the cause or consequence role of this AIEC strain in experimental
colitis/IBD.
The impact of experimental treatments on the microbiota
of the ileum was minor compared to other tested intestinal
segments. This suggests that CG-induced colitis has less effect on
the ileum, which indicates that CG may exhibit different impacts
on mucosal microbiota in different intestinal segments. One
point worth noting is that the proportion of Bacteroidetes was
consistently lower in the large intestine of pigs with CG-induced
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FIGURE 7 | Taxa that were positively or negatively associated with: (A) CG or CGUM146 in the descending colon of pigs treated with CG and
inoculated with adherent invasive Escherichia coli (AIEC) strain UM146; (B) control or UM146 in the descending colon of pigs inoculated with AIEC
UM146. CG: pigs received 1% CG only in the drinking water daily; CGUM146: pigs received CG from day 1 and were inoculated with AIEC UM146 on day 8; UM146:
pigs were inoculated with AIEC UM146 on day 8. Pigs in designated groups received 100 mL of AIEC UM146 culture (108 CFU/mL) in feed.
colitis compared to the colitic pigs that were also inoculated with
UM146 (Figure 3, Supplementary Table 1). This might suggest
that UM146 induced or enhanced proliferation of Bacteroidetes
in pigs with colitis, which is in agreement with some previous
studies in patients with CD that have reported increase in
Bacteroidetes, based on a recent systematic review (Wright
et al., 2015). The proliferation of Proteobacteria, especially
AIEC, has been consistently reported in IBD patients and in
experimental models of IBD, but it is still not clear if members
of this phylum cause inflammation or if their proliferation
is a result of inflammatory status in the gut (Mukhopadhya
et al., 2012). A recent study (Chassaing et al., 2014) found
that transient colonization with AIEC is sufficient to trigger
chronic intestinal inflammation in genetically susceptible hosts–
mice lacking Toll-like receptor 5 (TLR5), the sensor for bacterial
flagellin. Such chronic inflammation lasted even when AIEC was
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FIGURE 8 | Subsystems and pathways enriched or decreased in: (A) UM146 vs. CG; and (B) UM146 vs. CGUM146 of the ascending colon samples from
pigs treated with CG or inoculated with adherent invasive Escherichia coli (AIEC) strain UM146. Corrected P-values were calculated using the Storey’s FDR
correction. Subsystems or pathways overrepresented in the UM146 or (CG) samples had a positive or (negative) differences between mean proportions and were
indicated by red and (blue) color, respectively. Subsystems or pathways overrepresented in the UM146 or (CGUM146) samples had a positive or (negative) difference
between mean proportions and were indicated by red and (orange) color, respectively. CG: pigs received 1% CG only in the drinking water daily; CGUM146: pigs
received CG from day 1 and were inoculated with AIEC UM146 on day 8; UM146: pigs were inoculated with AIEC UM146 on day 8. Pigs in designated groups
received 100 mL of AIEC UM146 culture (108 CFU/mL) in feed.
no longer detectable and was also accompanied by alterations
in fecal microbial composition, loss of species diversity and
higher levels of LPS and flagellin. None of these alterations
were observed in wild-type mice/non-susceptible healthy hosts.
This supports a causal role of AIEC in IBD in genetically
susceptible hosts, but a consequent role in non-susceptible hosts,
and could partially explain our results in which AIEC strain
UM146 alone did not have much effect on inflammation or
microbial dysbiosis. However, because intestinal inflammation
may still persist even after AIEC is undetectable in the susceptible
host, AIEC may be an intestinal arsonist pathobiont that
ignites IBD and flees the scene in genetically susceptible hosts
(Jellbauer and Raffatellu, 2014). Still, it is not clear whether the
same process happens in healthy hosts that are not genetically
susceptible to IBD, which could also be the reason why the
pigs in our study did not have diarrhea beyond 48 h after
inoculation.
We identified bacterial taxa that were consistently associated
with particular treatments in all the four intestinal segments
examined, or shared in between two or three intestinal sections
(Figures 4–7). For example, Lactobacillus and Megasphaera
were positively associated with UM146 while Lactobacillus,
Helicobacter, and unclassified members of Streptococcaceae
were positively associated with CG treatment. On the other
hand, Prevotella, Ruminococcus, Oribacterium, Escherichia,
Coprococcus, Bulleidia, Veillonella, Mitsuokella, and unclassified
members of Enterobacteriaceae and RF39 were positively
associated with CGUM146. The mechanism by which UM146
and CG treatments were associated with Lactobacillus growth
is difficult to elucidate. It could be speculated that the changes
induced by the presence of CG or UM146 may favor specific
bacterial colonization. Moreover, the increased presence of
Lactobacillus in pigs exposed to UM146 and CG could be
relevant since these bacteria are protective against infections
including inflammatory and infectious diseases (Lara-Villoslada
et al., 2007). Lactobacillus may also produce lactate that can
be utilized by other bacteria to produce short chain fatty acids
(SCFA), which are metabolites that are well-known for their
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FIGURE 9 | Subsystems and pathways enriched or decreased in: (A) control vs. CG; and (B) control vs. CGUM146 of the descending colon samples
from pigs treated with CG and inoculated with adherent invasive Escherichia coli (AIEC) strain UM146. Corrected P-values were calculated using the
Storey’s FDR correction. Subsystems or pathways overrepresented in the control or (CG) pig descending colon samples had a positive or a (negative) difference
between mean proportions and were indicated by light green and (blue) color, respectively. Subsystems or pathways overrepresented in the control or (CGUM146) pig
samples had a positive or a (negative) difference between mean proportions and were indicated by light green and (orange) color, respectively. CG: pigs received 1%
CG only in the drinking water daily; CGUM146: pigs received CG from day 1 and were inoculated with AIEC UM146 on day 8; UM146: pigs were inoculated with AIEC
UM146 on day 8. Pigs in designated groups received 100 mL of AIEC UM146 culture (108 CFU/mL) in feed.
health benefits (Tsukahara et al., 2002), although our correlation
analysis did not reveal a strong association between some of
these taxa and various SCFA. Helicobacter pylori is commonly
found in the gut and under normal gut conditions, it does
not cause adverse effects; however, it is a major reason for the
genesis of gastritis and peptic ulcers in humans. Colonization of
gnotobiotic piglets with H. pylori is also associated with gastritis
and gastric ulcers (Heinritz et al., 2013). Interestingly, H. pylori
has been found to be negatively correlated with IBD, which may
be explained by the “hygiene hypothesis”, and only non-pylori
Helicobacters including Helicobacter hepaticus have been shown
to induce colitis in rodent models of experimental colitis (Hold
et al., 2014). It is therefore reassuring that perhaps H. hepaticus
was the major species associated with the CG treatment in the
colon in our study, even though our data was only classified to
the genus level and therefore it was not possible to definitively
discriminate between different species of the g. Helicobacter.
Some of the taxa were shared/positively associated with
specific treatments across different intestinal compartments,
which may imply strong relations between the taxa and
treatment conditions. Some taxa were positively correlated
with certain inflammatory cytokines/SCFAs (Table 4,
Supplementary Figures 1–3), reinforcing that different taxa
exhibit redundancy and pleiotropy, which makes elucidation
on their association with specific treatments difficult. However,
increased levels of Enterobacteriaceae have been repeatedly
reported in IBD patients, especially in CD, although results
related, but not limited, to Enterobacteriaceae, E. coli,
Bacteroides, and Lactobacillus species are not consistent
between studies (Takaishi et al., 2008; Andoh et al., 2011; Wright
et al., 2015). Such differences may be explained by variations in
sample sources, sampling locations, analytical methodologies
and disease activity among other confounding factors in separate
studies. Moreover, we only analyzed samples collected at one
time point, which is a limitation of our study and possibly
many other studies as it is not possible to discriminate between
“normal” changes and pathological conditions, and between
microbes that are transient and those that are permanent
residents of the gut.
Microbial activities in the gastrointestinal tract can result in
production of different metabolites, such as SCFA (for example
butyrate), substances with known immunoregulatory properties
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TABLE 4 | Correlation coefficient between selected taxaa and short chain fatty acids (acetic, propionic, butyric acid) and inflammatory markers in the
ileum, cecum and ascending colon.
GI segment Taxa Cytokine or SCFA Rho (ρ) P-values
Ileum g. Ruminococcus IL-1β 0.4714 0.026
IL-6 0.4987 0.018
IL-10 0.4498 0.035
f. Enterobacteriaceae IL-1β 0.4254 0.048
IL-8 0.5594 0.006
g. Prevotella IL-6 0.4411 0.039
IL-10 0.4509 0.035
f. Clostridiaceae IL-6 0.6862 < 0.001
g. Escherichia IL-8 0.4226 0.050
g. Faecalibacterium IL-10 0.5439 0.008
Butyrate 0.4696 0.027
g. Lactobacillus IL-10 −0.4617 0.030
g. Helicobacter Acetate 0.4229 0.049
g. Streptococcus Propionate 0.4336 0.043
Cecum g. Megasphaera IL-1β 0.4743 0.022
g. Desulfovibrio IL-10 0.58 0.003
TNF-α 0.4599 0.027
o. Bacteroidales Acetate 0.4555 0.028
g. Mucispirillum Acetate −0.579 0.003
Proprionate −0.4328 0.039
Butyrate −0.499 0.015
f. Erysipelotrichaceae Acetate −0.5365 0.008
Butyrate −0.5622 0.005
g. Anaerovibrio Proprionate −0.4367 0.037
g. Prevotella Butyrate 0.4555 0.028
g. Roseburia Butyrate −0.4189 0.046
g. Oscillospira Butyrate −0.4555 0.028
Ascending colon o. Clostridiales IL-6 0.5474 0.005
IL-8 −0.54 0.006
Acetate 0.6139 0.001
f. Ruminococcaceae IL-6 0.5062 0.011
IL-8 −0.4426 0.030
Acetate 0.6573 < 0.001
g. Oscillospira IL-6 0.5092 0.011
IL-8 −0.4773 0.018
Acetate 0.5391 0.006
g. Ruminococcus IL-6 0.5728 0.003
IL-8 −0.4547 0.025
Acetate 0.5426 0.006
Butyrate 0.4539 0.025
g. Desulfovibrio IL-6 0.6121 0.001
IL-8 0.6121 0.001
Acetate −0.4287 0.036
Butyrate −0.5887 0.002
g. Mucispirillum IL-6 −0.4274 0.037
IL-8 0.5634 0.004
Acetate −0.7356 < 0.001
Butyrate −0.6173 0.001
(Continued)
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TABLE 4 | Continued
GI segment Taxa Cytokine or SCFA Rho (ρ) P-values
o. RF39 IL-6 −0.4134 0.044
IL-8 −0.4134 0.044
Acetate 0.4569 0.024
g. Bacteroides IL-8 0.5649 0.004
Acetate −0.5231 0.008
g. Prevotella IL-8 −0.433 0.034
f. S24-7 IL-6 0.4835 0.016
IL-8 −0.4791 0.017
IL-10 −0.414 0.044
Acetate 0.7452 < 0.001
g. CF231 IL-8 −0.4596 0.023
g. Helicobacter IL-10 −0.4066 0.048
f. Veillonellaceae TNF-α −0.5579 0.004
g. Blautia Acetate 0.4321 0.034
g. Treponema Propionate 0.4217 0.040
g. Lactobacillus Propionate −0.4939 0.014
f. Streptococcaceae Propionate −0.452 0.026
Butyrate −0.4295 0.036
g. Campylobacter Acetate −0.5188 0.009
Butyrate −0.5366 0.006
g. Campylobacter Acetate −0.5188 0.009
Butyrate −0.5366 0.006
aTaxa with relative abundance ≥0.5% of the community were used for the correlation analysis and only the significant correlations are shown in the Table. SCFA, short chain fatty acid.
that greatly contribute to gut health (Sartor, 2008; Canani et al.,
2011; Smith et al., 2013). We observed a lower level of butyrate
in the cecum and colon digesta of pigs receiving CG (Table 2),
a condition that may be associated with poor colonocyte
development and an increase in inflammatorymarkers. However,
we did not observe much elevation in the inflammatory markers
in CG-treated pigs although the analysis was only performed
once and at the end of the experiment, and therefore, some
changes in cytokine levels during the course of the study may
have been missed. Since perturbations of the gut microbiota that
lead to pathological conditions are still not fully understood,
determining what aspects of the gut microbiota structurally and
functionally change in IBD conditions remains an important
part of research. Based on our functional metagenome prediction
results (Figures 8, 9), most of the categories associated with
the mucosal microbiota in control pigs that did not differ
from the pigs in the UM146 treatment included sugars,
starch, and sucrose metabolism, DNA replication, repair, and
recombination proteins, and transcription factors. Conversely,
the large intestine’s microbiota in CG-induced colitis (both
CG and CGUM146) was enriched with capacities associated
with secretion systems, lipopolysaccharide biosynthesis proteins,
membrane and structural molecules, and flagellar assembly.
Therefore, gut microbiota that were associated with CG-induced
colitis appear to have a reduced capacity for energy acquisition
and a dysregulated microbial signaling and repair pathways.
Lipopolysaccharide bacterial structures are known drivers of
inflammation whilst flagellar bacterial antigens have been
implicated as disease drivers in both mice models of colitis and
in IBD patients (Steiner, 2007).
In conclusion, our study has demonstrated that induction of
colitis using 1% CG caused intestinal bacterial dysbiosis. Certain
bacterial shifts observed in the distal GI tract as a result of CG
treatment are consistent with previous findings in IBD patients.
In this context, CG significantly influenced bacterial diversity
and induced notable microbial changes in the percentages of
the major phyla Firmicutes, Bacteroidetes, and Proteobacteria,
especially in the cecum, ascending, and descending colon. No
significant difference was observed between UM146 and the
control group, suggesting that the ability of UM146 to cause
bacterial dysbiosis may be limited in healthy subjects—a known
characteristic of opportunistic pathogens. Overall, CGwas shown
to be an acceptable model for mimicking human colitis in pigs,
but the role of UM146 in IBD needs further investigation.
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Supplementary Figure 1 | Correlation coefficient of selected taxa with the
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color depicts the strength of the correlation.
Supplementary Figure 3 | Correlation coefficient of selected taxa with
the short chain fatty acids (acetic, propionic and butyric acid)
and inflammatory markers in the descending colon. The blue color
shows a positive correlation while the coral color shows a negative
correlation. The intensity of the color depicts the strength of the
correlation.
Supplementary Table 1 | Analysis of the most abundant phyla in each
intestinal segment of pigs treated with carrageenan gum (CG)1 and
inoculated with adhered invasive Escherichia coli (AIEC) strain
UM1462.
Supplementary Table 2 | A summary showing mean relative abundances
of taxa in ileal mucosa samples.
Supplementary Table 3 | A summary showing mean relative abundances
of taxa in cecal mucosa samples.
Supplementary Table 4 | A summary showing mean relative abundances
of taxa in the ascending colon mucosa samples.
Supplementary Table 5 | A summary showing mean relative abundances
of taxa in the descending colon mucosa samples.
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